Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel 80mg/m2 weekly x 12 weeks
Sponsor: University of Michigan Rogel Cancer Center